Pathology reports after surgical resection reported that the patient with a CHEK2 mutation had an IPMN with moderate grade dysplasia, and the patient with a BRCA2 mutation had an IPMN with high-grade dysplasia and PanIN-1. The gene discussed is BRCA2; the disease is pancreatic intraductal papillary-mucinous neoplasm.